scispace - formally typeset
J

John Jeff Alvarado

Researcher at University of Pittsburgh

Publications -  16
Citations -  245

John Jeff Alvarado is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Proto-oncogene tyrosine-protein kinase Src & SH3 domain. The author has an hindex of 7, co-authored 11 publications receiving 192 citations. Previous affiliations of John Jeff Alvarado include Albert Einstein College of Medicine.

Papers
More filters
Journal ArticleDOI

Effector Kinase Coupling Enables High-Throughput Screens for Direct HIV-1 Nef Antagonists with Antiretroviral Activity

TL;DR: An assay that couples Nef to the activation of Hck, a Src family member and Nef effector protein is developed and a diphenylpyrazolo compound demonstrated submicromolar potency in HIV-1 replication assays against a broad range of primary Nef variants.
Journal ArticleDOI

Interaction with the Src Homology (SH3-SH2) Region of the Src-family Kinase Hck Structures the HIV-1 Nef Dimer for Kinase Activation and Effector Recruitment

TL;DR: The results suggest that in addition to serving as a kinase effector for Nef, Hck binding may reorganize the Nef dimer for functional interaction with other signaling partners.
Journal ArticleDOI

Structure of a microsporidian methionine aminopeptidase type 2 complexed with fumagillin and TNP-470.

TL;DR: Comparison of microsporidian Met AP2 structures with human MetAP2 provides insights into the design of inhibitors that might exhibit specificity for microsporaidiosis, particularly in patients that are immunosuppressed.
Journal ArticleDOI

Crystal Structure of the Src Family Kinase Hck SH3-SH2 Linker Regulatory Region Supports an SH3-dominant Activation Mechanism.

TL;DR: The crystal structure of a truncated Hck protein consisting of the SH2 and SH3 domains plus the linker supports the idea that these noncatalytic regions work together as a “conformational switch” that modulates kinase activity in a manner unique to the SH3 domain and linker topologies present in the intact Hckprotein.
Journal ArticleDOI

Discovery of a diaminoquinoxaline benzenesulfonamide antagonist of HIV-1 Nef function using a yeast-based phenotypic screen

TL;DR: Inhibitors of Nef function discovered with this assay, such as DQBS, may complement the activity of current antiretroviral therapies by enabling immune recognition of HIV-infected cells through the rescue of cell surface MHC-I.